课题基金 / 基金详情

CHEMOTHERAPY WITH DOXORUBICIN AND DOCETAXEL IN OPERABLE STAGE I BREAST CANCER

CHEMOTHERAPY WITH DOXORUBICIN AND DOCETAXEL IN OPERABLE STAGE I BREAST CANCER
多柔比星和多西紫杉醇在可手术 I 期乳腺癌中的化疗
批准号：
6263705
负责人：
LAURENCE HOWARD BAKER
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6263705
关键词：
breast neoplasms breath tests clinical research clinical trials doxorubicin drug screening /evaluation human subject human therapy evaluation metastasis neoplasm /cancer chemotherapy paclitaxel women's health

项目摘要

项目成果

LAURENCE HOWARD BAKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a single center investigator initiated trial designed primarily to estimate the response rate of Doxorubicin + Docetaxel (DD) used as primary chemotherapy in Stage I and II breast cancer, including the clinical response rate and the percentage of patients with complete pathologic response. Because we have recently found that the eruthromycin breath test predicts the pharmacokinetics of docetaxel, GCRC outpatient resources are being requested to administer this test on a single occasion to each woman enrolled in the study to determine whether the test predicts toxicity observed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative Core
Developmental Research Program
Integrated Translational Cancer Science Center
  • 批准号：
    8606928
  • 项目类别：
  • 资助金额：
    $40.0万
  • 财政年份：
    2014
  • 负责人：
    LAURENCE HOWARD BAKER
  • 依托单位：
    COLD SPRING HARBOR LABORATORY
Integrated Translational Cancer Science Center
  • 批准号：
    8868958
  • 项目类别：
  • 资助金额：
    $40.49万
  • 财政年份：
    2014
  • 负责人：
    LAURENCE HOWARD BAKER
  • 依托单位：
    COLD SPRING HARBOR LABORATORY
海外基金